Searched over 200M research papers
10 papers analyzed
Some studies suggest breast cancer incidence rates are rising globally and in specific populations, while other studies indicate stable or decreasing rates in certain demographics, with persistent racial disparities in mortality.
20 papers analyzed
Breast cancer remains the most common cancer among women worldwide, with significant variations in incidence rates across different regions and populations. Studies indicate that the incidence of breast cancer is generally higher in developed countries compared to less developed regions . For instance, in North America and Europe, the incidence rates are notably higher than in Africa and Asia . In Africa, the pooled crude incidence rate from population-based registries is approximately 24.5 per 100,000 person-years, with higher rates observed in North Africa compared to Sub-Saharan Africa.
Over the past few decades, the incidence of breast cancer has shown an upward trend in many parts of the world. In the United States, for example, the incidence rate has increased by 0.5% annually from 2010 to 2019, driven largely by localized-stage and hormone receptor-positive disease. Similarly, global data from 1990 to 2017 indicate a significant increase in the age-standardized incidence rate of female breast cancer, particularly in developing countries. This trend underscores the growing public health challenge posed by breast cancer globally.
Racial and ethnic disparities in breast cancer incidence and outcomes are well-documented. In the United States, while the incidence rate is slightly lower in Black women compared to White women, the mortality rate is significantly higher among Black women . This disparity is attributed to various factors, including differences in tumor biology, access to healthcare, and socioeconomic status. Black women also have the lowest five-year relative survival rates for most molecular subtypes of breast cancer.
Age is a critical factor in breast cancer incidence. Data from the United States show that breast cancer incidence rates have increased among women aged 20-39 years and decreased among women aged 50-64 and those aged 75 years and older. This suggests that younger women might benefit from discussions about breast cancer risk and preventive measures with their healthcare providers.
Breast density is another significant risk factor for breast cancer. Women with extremely dense breasts have a higher risk of developing breast cancer compared to those with fatty breasts. A study from Denmark found that women with the highest breast density had a 2.37 times higher risk of breast cancer compared to those with the lowest density. This highlights the importance of considering breast density in breast cancer screening and risk assessment.
The incidence of breast cancer is rising globally, with significant variations across regions, races, and age groups. Developed countries report higher incidence rates, while mortality rates are higher in less developed regions. Racial disparities in incidence and outcomes persist, particularly in the United States. Younger women and those with high breast density are at increased risk, underscoring the need for targeted screening and preventive strategies. Addressing these disparities and implementing effective screening programs are crucial steps in reducing the global burden of breast cancer.
Most relevant research papers on this topic